SCHEMBL31487985

SCHEMBL31487985

CCn1cnc(S(N)(=O)=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2E1 P05181 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ SMYD3 Q9H7B4 1/20 0.36
▸ CPB2 Q96IY4 3/20 0.35
▸ MAP3K5 Q99683 1/20 0.34
▸ CA2 P00918 3/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA7 P43166 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ CA13 Q8N1Q1 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CPB1 P15086 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9032506 0.81 CYP2E1 (0.40) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL9032448 0.81 CYP2E1 (0.40) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL20757533 0.79 KDM5A (0.44) —
SCHEMBL20760647 0.78 ADORA2A (0.37) CPB2CPB1
SCHEMBL22497173 0.78 ADORA2A (0.37) CPB2CPB1
SCHEMBL20761642 0.78 ADORA2A (0.37) CPB2CPB1
SCHEMBL31631836 0.74 DGAT1 (0.32) CA2CA12CA1CA9
SCHEMBL50543 0.74 LMNA (0.46) CYP2C9CYP2C19CA2CA12CA1
SCHEMBL28383604 0.72 PTGS2 (0.48) CA2CA12CA1CA7CA9
SCHEMBL22524860 0.71 TGFBR1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462555-A Sulfonamide compound and application thereof 上海科技大学 2025-02-18 — — CN disclosed
WO-2025031360-A1 SULFONAMIDE COMPOUND AND USE THEREOF 上海科技大学 2025-02-13 — — WO disclosed
Send feedback